[go: up one dir, main page]

NO900251L - Fremgangsmaate for behandling eller hindring av intrinsik aldret hud med retinoider. - Google Patents

Fremgangsmaate for behandling eller hindring av intrinsik aldret hud med retinoider.

Info

Publication number
NO900251L
NO900251L NO90900251A NO900251A NO900251L NO 900251 L NO900251 L NO 900251L NO 90900251 A NO90900251 A NO 90900251A NO 900251 A NO900251 A NO 900251A NO 900251 L NO900251 L NO 900251L
Authority
NO
Norway
Prior art keywords
retinoids
treatment
intrinsic
prevention
procedure
Prior art date
Application number
NO90900251A
Other languages
English (en)
Other versions
NO900251D0 (no
Inventor
Albert M Kligman
James A Mezick
Robert J Capetola
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25672393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO900251(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CA000588835A external-priority patent/CA1335651C/en
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of NO900251D0 publication Critical patent/NO900251D0/no
Publication of NO900251L publication Critical patent/NO900251L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Physical Vapour Deposition (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Fremgangsmåte for behandling eller hindring av intrlnsik aldret hud ved toplsk administrasjon av retinoider. Anvendelse av preparater inneholdende slike retinoider for nevnte behandling er også beskrevet.
NO90900251A 1989-01-19 1990-01-18 Fremgangsmaate for behandling eller hindring av intrinsik aldret hud med retinoider. NO900251L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29911989A 1989-01-19 1989-01-19
CA000588835A CA1335651C (en) 1989-01-20 1989-01-20 Method for the treatment or prevention of intrinsically aged skin with retinoids

Publications (2)

Publication Number Publication Date
NO900251D0 NO900251D0 (no) 1990-01-18
NO900251L true NO900251L (no) 1990-07-20

Family

ID=25672393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90900251A NO900251L (no) 1989-01-19 1990-01-18 Fremgangsmaate for behandling eller hindring av intrinsik aldret hud med retinoider.

Country Status (15)

Country Link
EP (2) EP0815840A3 (no)
JP (1) JP2931349B2 (no)
AT (1) ATE164513T1 (no)
AU (1) AU636595B2 (no)
DE (1) DE69032182T2 (no)
DK (1) DK0379367T3 (no)
ES (1) ES2115590T3 (no)
FI (1) FI114968B (no)
GR (1) GR3026573T3 (no)
IL (1) IL93106A0 (no)
MY (1) MY106263A (no)
NO (1) NO900251L (no)
PH (1) PH27578A (no)
PT (1) PT92905B (no)
SG (1) SG73394A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051449A (en) * 1991-02-27 1991-09-24 Kligman Albert M Treatment of cellulite with retinoids
FR2674127B1 (fr) * 1991-03-20 1993-06-11 Oreal Composition cosmetique pour lutter contre le vieillissement de la peau contenant en association au moins un retinouide et au moins une dialkyl- ou trialkylxanthine.
DE69503368D1 (de) 1994-04-12 1998-08-13 Kao Corp Dermatologisches präparat
EP0814799A1 (en) * 1995-03-20 1998-01-07 Allergan Use of retinoids for the manufacture of a medicament for the treatment of restenosis
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
CN100360121C (zh) * 1997-02-25 2008-01-09 密执安州立大学董事会 防护和处理人皮肤经时性衰老的方法和组合物
AU744809B2 (en) * 1997-03-11 2002-03-07 Pola Chemical Industries Inc. Method for evaluating skin conditioning agents and process for producing external skin preparations
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
USH2043H1 (en) 1997-05-23 2002-08-06 The Procter & Gamble Company Skin care compositions
DE19806946A1 (de) * 1998-02-19 1999-09-09 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Retinoid sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
DE19820392A1 (de) * 1998-05-07 1999-11-11 Beiersdorf Ag Wirkstoffkombinationen enthaltende Hautpflegemittel
FR2804323B1 (fr) * 2000-01-31 2006-07-07 Galderma Res & Dev Utilisation de composes de type retinoides en tant qu'agents anti-bacteriens
JP2002047125A (ja) * 2000-05-26 2002-02-12 Shiseido Co Ltd 皮脂分泌抑制用皮膚外用剤
JP2002284678A (ja) * 2001-03-23 2002-10-03 Ajinomoto Co Inc 皮膚外用剤
US20050202055A1 (en) 2004-03-11 2005-09-15 Koichi Shudo, Tokyo, Japan Anti-wrinkle agent
CN101431989B (zh) 2005-12-30 2011-11-23 雷文斯治疗公司 局部给药的精氨酸杂聚体
PT2056814E (pt) 2006-08-16 2014-08-25 Amderma Pharmaceuticals Llc Compostos de 2,5-di-hidroxibenzeno para o tratamento da psoríase
JP5665276B2 (ja) 2008-02-27 2015-02-04 花王株式会社 皮膚老化予防又は改善剤
EP2133066A1 (en) 2008-06-13 2009-12-16 Antonio Puig, S.A. Cosmetic and dermatological composition containing a mixture of retinol derivatives and tocotrienols.
WO2010072787A2 (en) 2008-12-22 2010-07-01 Johnson & Johnson Consumer France Sas A composition and method of treating skin conditions.
US11707442B2 (en) 2015-09-25 2023-07-25 The General Hospital Corporation Antibacterial and antifungal compounds
EA201891761A1 (ru) * 2016-02-03 2019-01-31 Галдерма Ресерч Энд Девелопмент Новые биароматические соединения пропинила, фармацевтические и косметические композиции, их содержащие, и их применение
CA3077331A1 (en) * 2017-09-28 2019-04-04 Johnson & Johnson Consumer Inc. Cosmetic compositions and method of treating the skin
GB2642547A (en) * 2024-07-12 2026-01-14 Univ Durham Compounds for use in senotherapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1466062A (en) * 1974-04-09 1977-03-02 Knight K Cosmetic preparations
FR2479819A1 (fr) * 1980-04-04 1981-10-09 Fabre Sa Pierre Le retinoate de zinc, sa preparation et les compositions topiques le contenant
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
EP0224504B1 (en) * 1985-04-22 1992-03-18 Avon Products, Inc. Composition and method for reducing wrinkles
FR2591105B1 (fr) * 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
JP2606711B2 (ja) * 1986-07-16 1997-05-07 エム． クリグマン，アルバート 日光で損傷されたヒトの皮膚のレチノイドによる治療方法
ZA879063B (en) * 1986-12-22 1989-04-26 Hoffmann La Roche Use of 13-cis retinoic acid
FR2612775B1 (fr) * 1987-03-25 1991-10-11 Thorel Jean Compositions pour la prevention et le traitement de la degenerescence cutanee
EP0357646B1 (en) * 1987-04-06 1995-03-22 Daltex Medical Sciences, Inc. Treatment of aged skin with oral 13-cis-retinoic acid

Also Published As

Publication number Publication date
EP0815840A2 (en) 1998-01-07
NO900251D0 (no) 1990-01-18
FI114968B (fi) 2005-02-15
ATE164513T1 (de) 1998-04-15
JPH02288822A (ja) 1990-11-28
PH27578A (en) 1993-08-18
EP0815840A3 (en) 1998-03-04
GR3026573T3 (en) 1998-07-31
AU636595B2 (en) 1993-05-06
SG73394A1 (en) 2000-06-20
AU4857390A (en) 1990-07-26
PT92905A (pt) 1990-07-31
ES2115590T3 (es) 1998-07-01
DK0379367T3 (da) 1998-10-19
JP2931349B2 (ja) 1999-08-09
FI900293A0 (fi) 1990-01-18
EP0379367A2 (en) 1990-07-25
EP0379367B1 (en) 1998-04-01
DE69032182D1 (de) 1998-05-07
PT92905B (pt) 1995-12-29
EP0379367A3 (en) 1991-04-24
DE69032182T2 (de) 1998-08-20
IL93106A0 (en) 1990-11-05
MY106263A (en) 1995-04-29

Similar Documents

Publication Publication Date Title
NO900251L (no) Fremgangsmaate for behandling eller hindring av intrinsik aldret hud med retinoider.
AU2118488A (en) Improvements in or relating to methods of treating damaged skin
DK154789A (da) Avendelse af topisk paafoerbare praeparater til behandling af aeldet hud
KR890004709A (ko) 항원충제로서의 아지트로마이신 및 이의 유도체
SE8504967L (sv) Farmaceutisk komposition och forfarande for behandling av kroppen
PT646012E (pt) Cura de feridas e tratamento de perturbacoes fibroticas por tgfbeta-3
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
ES2147780T3 (es) Compuestos sinteticos afines al extracto de corteza de roble, y procedimiento para utilizar los mismos.
BR9509006A (pt) Composiçao para aplicaçao tópica na pele composiçao farmacêutica uso de um inibidor de síntese de colesterol e processo para o tratamento mitigaçao ou prevençao de distúrbios de pele
NO940266L (no) Indre strålingsskade
AU6256996A (en) Use of vitamin D4 derivatives for treating skin disorders
MX9603596A (es) Perfluoropolieteres o composiciones de los mismos para prevencion y tratamiento de infecciones virales topicas.
FI951511A0 (fi) IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
MX9203374A (es) Composicion farmaceutica que contiene l-alfa-glicerofosforilcolina.
HU891056D0 (en) Process for treating the diseases of the gullet and the stomach-intestine system
AU4726797A (en) Prophylactic/remedial agent
FI961380A7 (fi) Koostumuksia virusten aiheuttamien kasvainten ehkäisemiseksi ja hoitam iseksi
GR3036827T3 (en) Method and composition for the treatment of hair loss.
FI904475A7 (fi) Tymopentiiniä sisältävät koostumukset ihosairauksien hoitamiseksi paik allisesti
HK17880A (en) N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide and derivatives
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
DE3775278D1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
ATE53004T1 (de) Pharmazeutische zusammensetzungen mit inhalt von 5-phenyl-1,3-dioxoalkenylverbindungen.
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.